Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Agreement TerminatedItem 1.02 · 8-KMEDIUM RiskNeutral

Harvard Apparatus Regenerative Technology, Inc.

Filed: Apr 13, 2026CIK: 0001563665
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Harvard Apparatus Regenerative Technology secured a $300,000 bridge loan from CEO Junli He at 8% interest, due by April 13, 2027 or upon a capital raise exceeding $5 million. This insider financing demonstrates the company's reliance on leadership support during a critical growth phase.

Key Takeaways

Company terminated a prior loan arrangement and restructured financing with a new $300,000 bridge note from the CEO

Loan carries an 8% annual fixed interest rate with dual maturity triggers: capital raise over $5M or April 13, 2027

2 more takeaways

Related Filings (1)

1 more filing from Harvard Apparatus Regenerative Technology, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateApr 13, 2026
Item1.02
CategoryAgreement Terminated
CIK0001563665
Accession #0001563665
Risk LevelMEDIUM
SentimentNeutral
Signalrisk
Topics
debt financingmaterial agreement

What This Means

A material agreement has been terminated. This could indicate a breakdown in a business relationship or strategic pivot.
View Full Filing on SEC.govBrowse More Filings